ISEE - IVERIC bio, Inc.
| Previous Close | 1.3300 |
| Open | 1.3300 |
| Bid | 1.2900 x 2200 |
| Ask | 1.3100 x 1800 |
| Day's Range | 1.2900 - 1.3300 |
| 52 Week Range | 1.0200 - 3.1300 |
| Volume | 27,493 |
| Avg. Volume | 165,993 |
| Market Cap | 54.335M |
| Beta (3Y Monthly) | 1.01 |
| PE Ratio (TTM) | 0.79 |
| EPS (TTM) | 1.6570 |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 2.85 |
- Simply Wall St.•29 days ago
Before You Buy IVERIC bio, Inc. (NASDAQ:ISEE), Consider Its Volatility
If you own shares in IVERIC bio, Inc. (NASDAQ:ISEE) then it's worth thinking about how it contributes to the...
- Zacks•last month
IVERIC bio's (ISEE) Q1 Loss Narrows, Gene Therapy in Focus
IVERIC bio (ISEE) first-quarter earnings beat estimates. The company is focusing on developing gene therapies for treating inherited retinal diseases.
- Associated Press•last month
Ophthotech: 1Q Earnings Snapshot
On a per-share basis, the New York-based company said it had a loss of 30 cents. The company's shares closed at $1.44. A year ago, they were trading at $2.63. _____ This story was generated by Automated ...
- Business Wire•last month
IVERIC bio Reports First Quarter 2019 Financial and Operating Results
- Conference Call and Webcast Today, May 8, 2019, at 8:00 a.m. ET -
- Business Wire•last month
IVERIC bio to Report First Quarter 2019 Financial Results and Host Conference Call on Wednesday, May 8, 2019
IVERIC bio today announced that it will report its first quarter 2019 financial and operating results on Wednesday, May 8, 2019. Following the announcement, IVERIC bio’s management team will host a live conference call and webcast at 8:00 a.m.
